Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2025-12-30 @ 11:04 AM
Study NCT ID:
NCT04143932
Status:
UNKNOWN
Last Update Posted:
2023-07-18
First Post:
2019-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multiple Myeloma Turkish Prospective Patient Registry
Sponsor:
Turkish Hematology Association
Organization:
Study Overview
Official Title:
Multiple Myeloma Patient Registry - Prospective National Multi Center Prospective Study
Status:
UNKNOWN
Status Verified Date:
2023-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
THD-MM-Reg
Brief Summary:
This is a non-interventional, national, multi center, prospective multiple myeloma registry in Turkey
Detailed Description:
In this study, approximately from 40 centers 1000 patients will be recruited. All patients will be followed-up till the study end.
All the laboratory results, treatment protocols and responses will be recorded and assessed with EORTC Multiple Myeloma Specific Quality of Life Multiple Myeloma Specific (MY-20) and EORTC Quality of Life-C30 questionnaires.
All the laboratory results, treatment protocols and responses will be recorded and assessed with EORTC Multiple Myeloma Specific Quality of Life Multiple Myeloma Specific (MY-20) and EORTC Quality of Life-C30 questionnaires.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: